Zydus Pharmaceuticals (USA) Inc Recalls

2 recalls found for Zydus Pharmaceuticals (USA) Inc — April 2026.

Medications: 2

The recalls listed below are active notices associated with Zydus Pharmaceuticals (USA) Inc in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.

A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.

Browse all medication recalls
NoticeMedications

Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,

Zydus Pharmaceuticals (USA) Inc

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

View recall →
NoticeMedications

Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,

Zydus Pharmaceuticals (USA) Inc

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

View recall →